The ACTIV-1 (ACCELERATING COVID-19 THERAPEUTIC INTERVENTIONS AND VACCINES) is a large randomized, placebo-controlled clinical trial led by the National Institutes of Health (NIH). The trial set out to determine if certain drugs that help minimize the effects of an overactive immune response could speed recovery and reduce deaths in adults hospitalized with moderate to severe COVID-19. […]
William Powderly, MD, protocol chair, and Jane O’Halloran, MD, PhD, WashU lead investigator of ACTIV-1 immune modulators trial showing reduction in COVID-19 mortality


















